Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 3Phase 1/2 2Phase EARLY_PHASE1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1NET 1Gynecologic 1Endocrine 1CNS 1

Conditions

Ovarian Neoplasms 8Breast Neoplasms 8Prostatic Neoplasms 5Small Cell Lung Carcinoma 4Stomach Neoplasms 3Neoplasms 3Lung Neoplasms 3Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Triple Negative Breast Neoplasms 2Recurrence 2Neuroendocrine Tumors 2Neoplasm Metastasis 2Glioma 2Uterine Neoplasms 1Urogenital Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Synovial 1Prostatic Neoplasms, Castration-Resistant 1Prostatic Diseases 1Pheochromocytoma 1Peritoneal Neoplasms 1Paraganglioma 1Pancreatic Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms by Site 1Metastatic Castration-Resistant Prostate Cancer 1Meningioma 1

Interventions

Dexamethasone 33Cyclophosphamide 29venetoclax 18fludarabine 18Lenalidomide 16Bortezomib 16Cytarabine 13pembrolizumab 12Calcium Dobesilate 12Carboplatin 11fludarabine phosphate 10Rituximab 10pomalidomide 9Gemcitabine 9Nivolumab 8Azacitidine 7daratumumab 6carfilzomib 6blinatumomab 6Decitabine 6Bendamustine Hydrochloride 6selinexor 5obinutuzumab 5ibrutinib 5Vincristine 5Temozolomide 5Methotrexate 5Etoposide 5Cisplatin 5tafasitamab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Recurrence × olaparib × Clear all
NCT06607692 2026-04-14

LUPARPED

Fundación de investigación HM

Phase 1/2 Recruiting
25 enrolled
CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT01650376 2018-03-23

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

Swedish Medical Center

Phase 1/2 Unknown
52 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡